Ole Lars Brekke

Ole Lars Brekke serves as an Adjunct Professor at the Department of Clinical Medicine, UiT The Arctic University of Norway. His academic position is part-time, reflecting his additional professional commitments outside the university. His work appears to be centered in Tromsø, Norway, where UiT's main campus is located.

Dr. Brekke's research primarily focuses on the complex interactions between the immune system and coagulation pathways. His work prominently features the complement system, thromboinflammation, and the relationship between bacterial infections and blood coagulation. A significant portion of his research investigates acute intermittent porphyria, examining its various manifestations including kidney and liver damage, dental complications, and inflammatory profiles. His laboratory work frequently utilizes human whole blood models to study complement activation, cytokine responses, and coagulation mechanisms.

Analysis of Dr. Brekke's publication record reveals consistent research themes centered on immunothrombosis - the intersection of immune responses and blood clotting. His most recent work (2022-2024) continues to explore complement activation pathways, particularly in relation to porphyria, bacterial infections, and neurological conditions. His research often involves collaboration with Tom Eirik Mollnes and other colleagues at UiT, suggesting established research groups focused on inflammation and coagulation.

While specific awards aren't mentioned in the available information, Dr. Brekke's extensive publication record in high-impact immunology and clinical journals demonstrates significant research productivity. His work has appeared in journals such as Journal of Immunology, Frontiers in Immunology, and Clinical and Experimental Immunology.

Dr. Brekke appears to work within research groups studying the complement system and its role in various disease processes. His publications frequently mention collaborations with researchers from UiT's Department of Clinical Medicine, suggesting active participation in research teams focused on inflammation, coagulation, and porphyria. His work with human whole blood models indicates specialized laboratory capabilities for studying immune-coagulation interactions in physiologically relevant systems.